ANEB Stock Summary and Trading Ideas (Anebulo Pharmaceuticals | NASDAQ:ANEB)

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.

Anebulo Pharmaceuticals trades on the NASDAQ stock market under the symbol ANEB.

As of February 13, 2026, ANEB stock price climbed to $0.48 with 42,414 million shares trading.

ANEB has a beta of 0.96, meaning it tends to be less sensitive to market movements. ANEB has a correlation of 0.01 to the broad based SPY ETF.

ANEB has a market cap of $19.54 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, ANEB traded as high as $4.05 and as low as $.44.

The top ETF exchange traded funds that ANEB belongs to (by Net Assets): VTI, VXF, IWC.

ANEB has underperformed the market in the last year with a price return of -64.0% while the SPY ETF gained +13.0%. ANEB has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -79.8% and -54.4%, respectively, while the SPY returned +1.7% and -1.5%, respectively.

ANEB support price is $.43 and resistance is $.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ANEB shares will trade within this expected range on the day.